Erratum: The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system (Journal of Pharmacology and Experimental Therapeutics (2014) 351 (390-402) DOI: 10.1124/jpet.114.218735);The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-Met system

Journal of Pharmacology and Experimental Therapeutics

Volumn 351, Issue 2, 2014, Pages 390-402

  Benoist, Caroline C ^a   Kawas, Leen H ^a,b   Zhu, Mingyan ^a   Tyson, Katherine A ^a   Stillmaker, Lori ^a   Appleyard, Suzanne M ^a   Wright, John W ^a,b   Wayman, Gary A ^a   Harding, Joseph W ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b M3 Biotechnology Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANGIOTENSIN II [3-8]; N HEXANOIC TYROSINE ISOLEUCINE (6) AMINOHEXANOIC AMIDE; NORLEUCINE; NORLEUCINE 1; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; ANGIOTENSIN II; ANGIOTENSIN II, DES ASP(1) DES ARG(2) ILE(5); ANGIOTENSIN II, DES-ASP(1)-DES-ARG(2)-ILE(5)-; DRUG DERIVATIVE; HGF ACTIVATOR; N HEXANOIC TYR ILE (6) AMINOHEXANOIC AMIDE; N-HEXANOIC-TYR-ILE-(6) AMINOHEXANOIC AMIDE; OLIGOPEPTIDE; PEPTIDE; SERINE PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIMERIZATION; DRUG POTENTIATION; DRUG PROTEIN BINDING; HIPPOCAMPAL CA1 REGION; INHIBITION KINETICS; MALE; MENTAL PERFORMANCE; MORRIS WATER MAZE TEST; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPINOGENESIS; SYNAPTOGENESIS; ANIMAL; CELL LINE; COGNITION; DOG; HEK293 CELL LINE; HIPPOCAMPUS; HUMAN; MDCK CELL LINE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPSE;

ANGIOTENSIN II; ANIMALS; CELL LINE; COGNITION; DOGS; HEK293 CELLS; HIPPOCAMPUS; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; MALE; OLIGOPEPTIDES; PEPTIDES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; RATS; RATS, SPRAGUE-DAWLEY; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 84908123329     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.218735concern     Document Type: Erratum

References (49)

1. Akimoto M, Baba A, Ikeda-Matsuo Y, Yamada MK, Itamura R, Nishiyama N, Ikegaya Y, and Matsuki N (2004) Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience 128:155-162.
2. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FA, Simpson RJ, and Connolly LM, et al. (2001) Evidence that the angiotensin IV (AT (4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276:48623-48626.
3. Albiston AL, Fernando RN, Yeatman HR, Burns P, Ng L, Daswani D, Diwakarla S, Pham V, and Chai SY (2010) Gene knockout of insulin-regulated aminopeptidase: loss of the specific binding site for angiotensin IV and age-related deficit in spatial memory. Neurobiol Learn Mem 93:19-30.
4. Bai L, Lennon DP, Caplan AI, DeChant A, Hecker J, Kranso J, Zaremba A, and Miller RH (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15:862-870.
5. Balschun D, Moechars D, Callaerts-Vegh Z, Vermaercke B, Van Acker N, Andries L, and D'Hooge R (2010) Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning. Cereb Cortex 20:684-693.
6. Benoist CC, Wright JW, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2011) Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs. J Pharmacol Exp Ther 339:35-44.
7. Braszko JJ, Kupryszewski G, Witczuk B, and Wisniewski K (1988) Angiotensin II-(3-8) - hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27:777-783.
8. Chen JK, Zimpelmann J, Harris RC, and Burns KD (2001) Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. Am J Physiol Renal Physiol 280:F980-F988.
9. Date I, Takagi N, Takagi K, Kago T, Matsumoto K, Nakamura T, and Takeo S (2004) Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats. J Neurosci Res 78:442-453.
10. 4receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation. Neuroscience 137:1369-1379.
11. Doeppner TR, Kaltwasser B, ElAli A, Zechariah A, Hermann DM, and Bähr M (2011) Acute hepatocyte growth factor treatment induces long-term neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and differentiation. J Cereb Blood Flow Metab 31:1251-1262.
12. Ebens A, Brose K, Leonardo ED, Hanson MG, Jr, Bladt F, Birchmeier C, Barres BA, and Tessier-Lavigne M (1996) Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17:1157-1172.
13. (4) receptors. J Physiol Pharmacol 57:329-342.
14. Ferreira A and Rapoport M (2002) The synapsins: beyond the regulation of neurotransmitter release. Cell Mol Life Sci 59:589-595.
15. Gherardi E, Sandin S, Petoukhov MV, Finch J, Youles ME, Ofverstedt LG, Miguel RN, Blundell TL, Vande Woude GF, and Skoglund U, et al. (2006) Structural basis of hepatocyte growth factor/scatter factor and MET signalling. Proc Natl Acad Sci USA 103:4046-4051.
16. Hamilton TA, Handa RK, Harding JW, and Wright JW (2001) A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat. Peptides 22:935-944.
17. Handa RK (2001) Characterization and signaling of the AT (4) receptor in human proximal tubule epithelial (HK-2) cells. J Am Soc Nephrol 12:440-449.
18. Kadoyama K, Funakoshi H, Ohya W, and Nakamura T (2007) Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS. Neurosci Res 59:446-456.
19. Kato S, Funakoshi H, Nakamura T, Kato M, Nakano I, Hirano A, and Ohama E (2003) Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation. Acta Neuropathol 106:112-120.
20. Kawas LH, Yamamoto BJ, Wright JW, and Harding JW (2011) Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity. J Pharmacol Exp Ther 339:509-518.
21. Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, and Harding JW (2012) Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. J Pharmacol Exp Ther 340:539-548.
22. Kawas LH, Benoist CC, Harding JW, Wayman GA, and Abu-Lail NI (2013) Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy. Nanomedicine (Lond Print) 9:428-438.
23. Kitamura K, Fujiyoshi K, Yamane J, Toyota F, Hikishima K, Nomura T, Funakoshi H, Nakamura T, Aoki M, and Toyama Y, et al. (2011) Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PLoS ONE 6:e27706.
24. Koike H, Ishida A, Shimamura M, Mizuno S, Nakamura T, Ogihara T, Kaneda Y, and Morishita R (2006) Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease. Gene Ther 13:1639-1644.
25. 4receptor subtypes. Regul Pept 68:131-138.
26. Kramár EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, and Wright JW (2001) The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Res 897:114-121.
27. Lan F, Xu J, Zhang X, Wong VW, Li X, Lu A, Lu W, Shen L, and Li L (2008) Hepatocyte growth factor promotes proliferation and migration in immortalized progenitor cells. Neuroreport 19:765-769.
28. Li YD, Block ER, and Patel JM (2002) Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol 283:L707-L716.
29. McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, and Harding JW (2013) Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. J Pharmacol Exp Ther 344:141-154.
30. Müller AM, Jun. E, Conlon H, and Sadiq SA (2012) Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis. J Neuroimmunol 251:80-86.
31. Nicoleau C, Benzakour O, Agasse F, Thiriet N, Petit J, Prestoz L, Roger M, Jaber M, and Coronas V (2009) Endogenous hepatocyte growth factor is a niche signal for subventricular zone neural stem cell amplification and self-renewal. Stem Cells 27:408-419.
32. Peters S and Adjei AA (2012) MET: a promising anticancer therapeutic target. Nat Rev Clin Oncol 9:314-326.
33. 4receptor subtype in overcoming scopolamine-induced spatial memory deficits. Regul Pept 102:147-156.
34. Salehi Z and Rajaei F (2010) Expression of hepatocyte growth factor in the serum and cerebrospinal fluid of patients with Parkinson's disease. J Clin Neurosci 17:1553-1556.
35. Shang J, Deguchi K, Yamashita T, Ohta Y, Zhang H, Morimoto N, Liu N, Zhang X, Tian F, and Matsuura T, et al. (2010) Antiapoptotic and antiautophagic effects of glial cell line-derived neurotrophic factor and hepatocyte growth factor after transient middle cerebral artery occlusion in rats. J Neurosci Res 88:2197-2206.
36. Shimamura M, Sato N, Sata M, Wakayama K, Ogihara T, and Morishita R (2007) Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats. Brain Res 1151:188-194.
37. Stella MC and Comoglio PM (1999) HGF: a multifunctional growth factor controlling cell scattering. Int J Biochem Cell Biol 31:1357-1362.
38. Stubley-Weatherly L, Harding JW, and Wright JW (1996) Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats. Brain Res 716:29-38.
39. Tyndall SJ, Patel SJ, and Walikonis RS (2007) Hepatocyte growth factor-induced enhancement of dendritic branching is blocked by inhibitors of N-methyl-D-aspartate receptors and calcium/calmodulin-dependent kinases. J Neurosci Res 85:2343-2351.
40. Wang TW, Zhang H, Gyetko MR, and Parent JM (2011) Hepatocyte growth factor acts as a mitogen and chemoattractant for postnatal subventricular zone-olfactory bulb neurogenesis. Mol Cell Neurosci 48:38-50.
41. Wayman GA, Impey S, Marks D, Saneyoshi T, Grant WF, Derkach V, and Soderling TR (2006) Activity-dependent dendritic arborization mediated by CaM-kinase I activation and enhanced CREB-dependent transcription of Wnt-2. Neuron 50:897-909.
42. Wayman GA, Davare M, Ando H, Fortin D, Varlamova O, Cheng HY, Marks D, Obrietan K, Soderling TR, and Goodman RH, et al. (2008) An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci USA 105:9093-9098.
43. Wayner MJ, Armstrong DL, Phelix CF, Wright JW, and Harding JW (2001) Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides 22:1403-1414.
44. Wright JW and Harding JW (2010) The brain RAS and Alzheimer's disease. Exp Neurol 223:326-333.
45. Wright JW and Harding JW (2013) The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. Pflugers Arch 465:133-151.
46. 4receptor subtype system to spatial learning. J Neurosci 19:3952-3961.
47. Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, and Harding JW (2010) The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2) 3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. J Pharmacol Exp Ther 333:161-173.
48. Youles M, Holmes O, Petoukhov MV, Nessen MA, Stivala S, Svergun DI, and Gherardi E (2008) Engineering the NK1 fragment of hepatocyte growth factor/scatter factor as a MET receptor antagonist. J Mol Biol 377:616-622.
49. Zhang YW and Vande Woude GF (2003) HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem 88:408-417.